Search

everythinglearnresearchcommunity

for

Search:↓

ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

The botanical treatment for hair loss shows promise, especially for children.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Drug metabolism affects how long a drug works, its interactions, activation, and toxicity, and is influenced by genetics, diet, illness, and other drugs.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Topical minoxidil does not change the activity of hair follicle enzymes that metabolize it.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.